Overview
Singer Finance provides lending, leasing and deposit-funded finance through branches and digital channels, with vehicle finance a key activity. The central change is rapid balance-sheet expansion funded in part by successive rights issues: September-quarter revenue and profit both increased year-on-year, but revenue grew faster and the profit margin narrowed.
Price performance
The share closed at LKR 44.30 on 12 November 2026. It was down 35.5% over one year while the ASPI fell 3.5%, so the company has materially lagged the wider market over that period. The price sits 24.7% up its 52-week range from the low, rather than near the high.
The three-year record contains four falls of 15% or more, with the deepest 51.3% decline yet to recover. Trading is thin: a LKR 1 million order is more than everything that trades on a typical day, or 122% of median daily turnover, making that order a large part of a normal session.
Valuation
At 6.9 times P/E, the market price represents 6.9 rupees for every rupee of trailing profit, while the 1.2 times P/B means 1.2 rupees for each rupee of net assets. The latest audited-year ROE was 16.3%, supporting some premium to book value relative to a lender earning less on equity.
The shares were more expensive on P/B than at 12 of the last 15 year-ends, even though the market-wide valuation score of 79 out of 100 places them in the moderately undervalued band. A buyer at this price is relying partly on the September quarter, which supplied 25.3% of trailing EPS; if that quarter had earned its year-ago margin, P/E would be 6.6 times.
The dividend yield is 2.2%, below the sector median, and the FY2026 dividend of LKR 0.988 per share is below the LKR 1.32 recorded for FY2022. The payout is modest relative to earnings, rather than the main element of the valuation case.
News and sentiment
Coverage was unusually quiet, with one article in the last 30 days against a normal monthly rate of two. Of 10 material articles over 90 days, three were positive and none negative, while most concerned governance appointments or corporate actions rather than operating results.
The material event was the completed 8:29 rights issue, which went ex on 16 October 2026 at LKR 39.20 per share. Holders who did not take up the offer were diluted, while the company received fresh capital intended for capital adequacy and lending. The LKR 1.00 interim dividend had an ex-date of 12 June 2026, so a buyer today does not receive it.
Financials
September-quarter revenue rose 38.4% year-on-year to LKR 2.8 billion, but operating profit increased 18.6% and net profit 15.9% to LKR 464 million. Profit therefore grew more slowly than the lending income behind it.
Gross margin is not applicable from the available finance-company income presentation. Operating margin fell from 45.0% to 38.6%, while net margin declined from 19.7% to 16.5%. The latter was the fourth-best September result out of seven comparable September quarters, so it was middling against the company's own like-for-like record rather than an exceptional weak print.
LKR 620 million of operating profit was absorbed below the operating line, up from LKR 514 million a year earlier, which explains why the rise in operating profit did not translate fully into net profit. Shares outstanding rose from 202.1 million a year earlier to 277.9 million following rights issues, so EPS comparisons are affected mechanically by the larger share base; the absolute profit increase is the clearer operating measure.
Risks
The main risk is funding and balance-sheet leverage during a rapid expansion of lending. Total liabilities were 9.04 times equity at March 2026, up from 8.36 times a year earlier, meaning a relatively small change in asset quality, funding cost or credit losses can have a larger effect on shareholder equity.
Total debt reached LKR 42.8 billion at September 2026, alongside LKR 10.3 billion of equity. The October rights issue strengthens the equity base, but it also enlarged the ordinary share count and requires incremental lending to earn an adequate return on the added capital.
The operating margin contraction is the next business risk. September net profit still grew, but the lower margin means the current earnings base is less efficient than the comparable prior-year quarter. Sector conditions also include falling government-bond yields but elevated October inflation, a mixed environment for financial-sector funding, lending and asset valuations.
Outlook
As at 12 November 2026, the next scheduled evidence is the interim quarter ending 31 December 2026, expected to be filed between 4 and 14 February 2027. It will show whether the capital raised through the October rights issue is translating into additional lending income without further erosion in profitability.
The available data cannot establish loan quality, capital-adequacy ratios or the funding mix after the rights issue. The December filing is therefore the first scheduled company-specific update that can test how the larger equity base and expanding assets are affecting earnings.